Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1331201

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of who should be eligible to receive the Janssen covid-19 vaccine.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13066
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Deployment decisions for the Janssen vaccine within the COVID-19 vaccine programme are currently under consideration. The Department will be guided by the advice from the Joint Committee on Vaccination and Immunisation before making a final decision.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/06/2021 12:21:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1331269

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to (a) pages 22 to 23 of Public Health England's COVID-19 - SARS-CoV-2 Green Book Chapter 14a, published on 7 May 2021, and (b) the Medicines & Healthcare products Regulatory Agency's Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca, 4.4, published on 15 April 2021, whether he has made an assessment of whether (i) previous experience of thrombosis and (ii) the presence of thrombophilia such as antiphospholipid syndrome should be treated as contraindications for (A) Pfizer/BioNTech, (B) Oxford/AstraZeneca, (C) Moderna and (D) Janssen Covid-19 vaccination in relation to risks of vaccine–induced immune thrombocytopenia and thrombosis.
tabling member constituency	West Ham
tabling member printed	Ms Lyn Brown
uin	13001
answer	answer is ministerial correction date of answer 24/06/2021 answer text <p>The Medicines and Healthcare products Regulatory Agency has undertaken a thorough review into reports of an extremely rare specific type of blood clot in the brain in the United Kingdom, following vaccination with the Oxford/AstraZeneca vaccine. It is also considering other types of blood clots alongside low platelet levels. No risk factors for this unusual type of clotting disorder have been identified although the MHRA is continuing to monitor the emerging data.</p><p>There is no evidence those with a history of common types of thrombosis are more at risk of developing rare blood clots with low platelets after vaccination. Therefore, the use of the AstraZeneca vaccine in individuals with a history of these conditions is not currently a contraindication. Individuals with past clotting episodes without low platelets and those diagnosed with thrombophilia remain at risk of COVID-19 disease and should be vaccinated with any of the available vaccines. However, as a precautionary measure, administration of the AstraZeneca vaccine in patients with a history of cerebral venous sinus thrombosis or antiphospholipid syndrome should only be considered when the benefit outweighs any potential risks and use is contraindicated in those who have experienced major clots with low platelets after any COVID-19 vaccine or after exposure to heparin.</p><p>These rare events have also been reported in other countries with the Janssen vaccine. However, no predisposing risk factors have been identified. The available evidence does not suggest an increased risk of these rare events following administration of either the Pfizer/BioNTech or Moderna vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 24/06/2021 10:05:51 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 6341 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1583 label Biography information for Ms Lyn Brown

1331347

registered interest
date	09/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Medicines and Diagnostics Manufacturing Transformation Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what the uptake has been of funding from the Medicines and Diagnostics Manufacturing Transformation Fund to date.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	13145
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Since the Medicines &amp; Diagnostics Manufacturing Transformation Fund (MDMTF) launched on 7 April this year, we have seen a high level of interest from the sector with a total of 80 registrations visible on the online application portal as of 11<sup>th</sup> June 2021. The application deadline for the MDMTF is not until 30 June. Once received, applications will be appraised before grant offers are made.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/06/2021 10:54:02 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4488 label Biography information for Martyn Day

1331359

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Employment: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that workplaces release staff for their covid-19 vaccine.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	13126
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Employers are encouraged to discuss whether staff need time off to be vaccinated, as well as adjusting working schedules accordingly to accommodate those who are absent due to receiving the vaccine.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/06/2021 10:43:47 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 6327 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1331411

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people no immigration status are able to access covid-19 vaccinations.
tabling member constituency	Glasgow Central
tabling member printed	Alison Thewliss
uin	13113
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of immigration status.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 13114 question first answered 18/06/2021 10:47:20 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 6320 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4430 label Biography information for Alison Thewliss

1331415

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people without immigration status will be able to access covid-19 vaccination.
tabling member constituency	Glasgow Central
tabling member printed	Alison Thewliss
uin	13114
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of immigration status.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 13113 question first answered 18/06/2021 10:47:20 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 6331 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4430 label Biography information for Alison Thewliss

1331424

registered interest
date	09/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Liberty Steel: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what support he plans to provide to people at risk of losing their jobs in Dudley North constituency due to Liberty Steel selling off plants in West Bromwich and Kidderminster.
tabling member constituency	Dudley North
tabling member printed	Marco Longhi
uin	13236
answer	answer is ministerial correction date of answer 16/06/2021 answer text <p>We recognise that this is an unsettling time for Liberty Steel’s workforce. The Government stands ready to support Liberty’s dedicated employees and their families affected by any developments, should the need arise. However, it is first and foremost the responsibility of the company to manage commercial decisions regarding the future of the organisation.</p><p> </p><p>We hope the company is successful in their endeavours in selling these assets. We will continue to engage closely with company and trade unions as the situation develops. Conversations with Liberty or any other company are, of course, commercially confidential</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 16/06/2021 15:30:17 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4789 label Biography information for Marco Longhi

1331484

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department's guidance is on how soon after recovering from a covid-19 infection a person can receive a covid-19 vaccination.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	13202
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Public Health England has issued guidance for healthcare practitioners which states that vaccination should be deferred in those who have tested positive for COVID-19 infection until they have recovered approximately four weeks after the onset of symptoms, or four weeks from the first confirmed positive test in those who are asymptomatic. This guidance is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/covid-19-vaccination-programme-guidance-for-healthcare-practitioners" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccination-programme-guidance-for-healthcare-practitioners</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/06/2021 10:39:11 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 6323 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1331494

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on whether the efficacy of the covid-19 vaccine reduces in the period beyond six months after receipt.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	13137
answer	answer is ministerial correction date of answer 16/06/2021 answer text <p>Public Health England (PHE) continues to monitor the efficacy of the COVID-19 vaccination. PHE will report the findings on efficacy after six months in due course, as more people are vaccinated.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 16/06/2021 16:00:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1331507

registered interest
date	09/06/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Clean Steel Fund
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the effect on (a) the steel industry and (b) meeting the UK’s net zero targets of the clean steel fund not starting until 2023.
tabling member constituency	Feltham and Heston
tabling member printed	Seema Malhotra
uin	13071
answer	answer is ministerial correction date of answer 14/06/2021 answer text <p>The Department announced the Clean Steel Fund (CSF) in 2019 and developments are currently underway. This policy will take time to design in order to be delivered effectively.</p><p>Based on previous evidence, complex decarbonisation projects have long lead-in times and take time to set up. Due to this and other factors, the steel sector indicated in response to the 2019 Call for Evidence that their preference is for the CSF to be launched in 2023. Other schemes are available to support the sector and are live now, including the Industrial Energy Transformation Fund.</p><p>Decarbonising UK industry is a core part of the Government’s ambitious plan for the green industrial revolution. The Industrial Decarbonisation Strategy, published on 17 March, indicated our commitment to work with the Steel Council to consider the implications of the recommendation of the Climate Change Committee to ‘set targets for ore-based steelmaking to reach near-zero emissions by 2035’.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/06/2021 11:10:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4253 label Biography information for Seema Malhotra